To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
The Winners and Losers of 340B Changes
What CMS' big changes to the 340B Drug Discount Program will mean.
Read more
 
Emicizumab-kxwh for Hemophilia A
What you need to know about the recently-approved Hemlibra.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.